P-263: Matching-adjusted indirect treatment comparison (MAIC) of teclistamab vs approved therapies for the treatment of patients with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM)
Year: 2022
Type: conference-abstract
Authors: Philippe Moreau, Saad Usmani, Niels W.C.J. van de Donk, Alfred Garfall, Michel Delforge, Albert Oriol, Ajay Nooka, Laura Rosiñol, Nizar Bahlis, Paula Rodríguez-Otero, Thomas Martin, Joris Diels, Suzy Van Sanden, Lixia Pei, Eric Ammann, Rachel Kobos, Alexander Marshall, Mary Slavcev, Jennifer Smit, Anil Londhe, Amrita Krishnan
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4293107911